---
$id: https://graph.org.ai/products/commodity/51142536
$type: Product
source: UNSPSC
code: "51142536"
title: "Piribedil"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Piribedil

**UNSPSC Code**: 51142536
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist with the molecular formula C16H18N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DO22K1PRDJ, chemically known as 2-(4-(3,4-methylenedioxybenzyl)piperazino)pyrimidine but generally known as piribedil, which bears US NIH Compound Identifier 4850. European Medicines Agency schedules Piribedil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09908MIG. The term PIRIBEDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules piribedil in its Anatomical Therapeutic Chemical (ATC) Classification. PIRIBEDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piribedil under HS 29349990 and SITC 51579. As of Q4 2014, PIRIBEDIL remains the US FDA Preferred Term for this commodity. Piribedil bears US NLM identifiers UMLS ID C0031979 and NCI Concept Code C81082. SMILES: O1C2CC(CN3CCN(CC3)C3NCCCN3)CCC2OC1.

